Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.
Coronavirus
As coronavirus concerns grow, Gladstone's virology experts are here to answer your questions, offer insight, provide context, and discuss the impacts of the outbreak on public health.
Gladstone virology experts are available for media interviews.
At Gladstone, we believe that basic science will be key for identifying potential drug targets and creating an effective vaccine. Both are sorely needed. Antivirals that can control coronavirus growth could have a huge impact not only on disease outcome but also on virus transmission from one person to another.
Contact
Julie Langelier
Associate Director, Communications
Direct line: 415.734.5000
Email
Megan McDevitt
Vice President of Communications
Direct line: 415.734.2019
Cell: 404.547.3519
Email
News Releases
16 - 30 of 145 Results
Zeroing in on a New Treatment for Autism and Epilepsy
Zeroing in on a New Treatment for Autism and Epilepsy
Gladstone scientists show that reducing levels of the protein tau soon after birth can prevent these conditions in an experimental model
News Release Research (Publication) Epilepsy Neurological Disease Mucke LabA New Toolkit To Engineer Safe and Efficient Therapeutic Cells
A New Toolkit To Engineer Safe and Efficient Therapeutic Cells
Scientists from Gladstone and UC San Francisco systematically tested ways to improve the efficacy of therapeutic cells targeting cancer
News Release Research (Publication) Cancer Genomic ImmunologyMini-Livers on a Chip
Mini-Livers on a Chip
A new platform designed by Gladstone scientists for studying how the immune system responds to hepatitis C virus could speed the hunt for a vaccine
News Release Research (Publication) Hepatitis C Virology McDevitt Lab Ott Lab OrganoidsDetermining Genetic Risk for the Forgotten
Determining Genetic Risk for the Forgotten
Catherine Tcheandjieu joins Gladstone Institutes to uncover what predisposes people from diverse ancestries to disease
Institutional News News Release Profile Cardiovascular Disease Data Science and Biotechnology Tcheandjieu LabHow Obesity Can Rewire the Immune System and the Response to Immunotherapy—and How to Change That
How Obesity Can Rewire the Immune System and the Response to Immunotherapy—and How to Change That
Researchers have discovered why immune treatments for allergies and asthma might not be as effective in obese mice and humans
News Release Research (Publication) Genomic Immunology Marson LabGetting to the Heart of Complex Disease
Getting to the Heart of Complex Disease
Gladstone researchers develop robust strategy for sifting through large-scale genetic data to better understand congenital heart problems
News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Krogan Lab Pollard Lab Srivastava Lab Stem Cells/iPSCsScientists Reveal “Rosetta Stone” of Immune Cell Function
Scientists Reveal “Rosetta Stone” of Immune Cell Function
Researchers adapt a variation of the CRISPR-Cas9 system to activate genes in human immune cells and study the consequences
News Release Research (Publication) Genomic Immunology Marson Lab CRISPR/Gene EditingMutant Stem Cells Defy Rules of Development
Mutant Stem Cells Defy Rules of Development
Removing one gene from developing heart cells suddenly makes them turn into brain cell precursors, making researchers rethink cellular identity
News Release Research (Publication) Cardiovascular Disease Bruneau Lab Stem Cells/iPSCsKaterina Akassoglou Elected Lifetime AAAS Fellow
Katerina Akassoglou Elected Lifetime AAAS Fellow
Gladstone investigator receives distinct honor within the scientific community
Awards News Release Neurological Disease Akassoglou LabResearchers Pioneer New Method to Edit Genes in Human Cells
Researchers Pioneer New Method to Edit Genes in Human Cells
Retrons could revolutionize gene editing for research and medicine
News Release Research (Publication) Data Science and Biotechnology Shipman Lab CRISPR/Gene EditingStrains—not Species—of Gut Microbes Hold Key to Health and Disease
Strains—not Species—of Gut Microbes Hold Key to Health and Disease
Two new studies underscore the importance of looking at bacterial strains when analyzing the human gut microbiome
News Release Research (Publication) Data Science and Biotechnology Pollard Lab Big Data MicrobiomeA New Class of Antiviral Therapy Could Treat COVID-19
A New Class of Antiviral Therapy Could Treat COVID-19
Gladstone scientists develop a single-dose intranasal treatment that is effective against variants of the SARS-CoV-2 virus
News Release Research (Publication) COVID-19 Virology Weinberger Lab ChaturvediNew Tech Assigns More Accurate “Time of Death” to Cells
New Tech Assigns More Accurate “Time of Death” to Cells
The method lets researchers more easily study factors that can lead to cell death, in conditions including neurodegenerative diseases
News Release Research (Publication) Center for Systems and TherapeuticsKaterina Akassoglou Elected to National Academy of Inventors
Katerina Akassoglou Elected to National Academy of Inventors
Gladstone scientist receives highest distinction for academic inventors
Awards News Release Multiple Sclerosis Alzheimer’s Disease Center for Neurovascular Brain Immunology Akassoglou LabIt Takes Guts to Make a Heart
It Takes Guts to Make a Heart
Gladstone scientists create novel organoids that open new doors for understanding crosstalk between tissues during human development
News Release Research (Publication) Cardiovascular Disease McDevitt Lab Organoids
